Steward Partners Investment Advisory, LLC Alkermes Plc. Transaction History

Steward Partners Investment Advisory, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$27.17 - $31.97 $2,581 - $3,037	-95 Reduced 38.0%	155 $4,000
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $21,255 - $25,222	-750 Reduced 75.0%	250 $7,000
Q1 2022 May 02, 2022	BUY	$23.07 - $27.99 $11,535 - $13,995	500 Added 100.0%	1,000 $26,000
Q4 2021 Feb 08, 2022	BUY	$21.47 - $32.08 $10,735 - $16,040	500 New	500 $12,000
Q1 2020 Apr 29, 2020	SELL	$13.06 - $21.24 $2,598 - $4,226	-199 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$17.29 - $21.74 $220,136 - $276,793	-12,732 Reduced 98.46%	199 $4,000
Q3 2019 Oct 30, 2019	BUY	$19.51 - $24.28 $250,898 - $312,240	12,860 Added 18112.68%	12,931 $252,000
Q2 2019 Jul 25, 2019	BUY	$21.47 - $37.33 $1,524 - $2,650	71 New	71 $1,000
Q4 2018 Jan 15, 2019	SELL	$27.94 - $44.61 $49,369 - $78,825	-1,767 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$38.6 - $46.12 $15,015 - $17,940	389 Added 28.23%	1,767 $75,000
Q2 2018 Jul 20, 2018	BUY	$40.56 - $51.36 $11,113 - $14,072	274 Added 24.82%	1,378 $57,000
Q1 2018 Apr 20, 2018	BUY	$53.61 - $67.26 $59,185 - $74,255	1,104 New	1,104 $63,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.14B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.